Risk Factors for Prolonged Ileus After Resection of Colorectal Cancer: An Observational Study of 2400 Consecutive Patients : Annals of Surgery

Journal Logo

Original Articles

Risk Factors for Prolonged Ileus After Resection of Colorectal Cancer

An Observational Study of 2400 Consecutive Patients

Chapuis, Pierre H. DS, FRACS; Bokey, Les MS, FRACS; Keshava, Anil FRACS; Rickard, Matthew J.F.X. FRACS; Stewart, Peter FRACS; Young, Christopher J. FRACS; Dent, Owen F. PhD

Author Information
Annals of Surgery 257(5):p 909-915, May 2013. | DOI: 10.1097/SLA.0b013e318268a693

Objective: 

Prolonged ileus—the failure of postoperative ileus to resolve within a few days after major abdominal surgery—leads to significant medical consequences for the patient and costs to the hospital system. The aim of this retrospective analysis of prospectively collected data was to identify independent preoperative and intraoperative risk factors for prolonged ileus in a large consecutive series of patients who had undergone resection for colorectal cancer.

Methods: 

Patients were drawn from a hospital registry of 2400 consecutive resections over the period 1995–2009. Thirty-four potential predictors of prolonged ileus were analyzed by logistic regression.

Results: 

Prolonged ileus occurred in 14.0% of patients. Statistically significant independent predictors of prolonged ileus were male sex (OR: 1.7, P < 0.001), peripheral vascular disease (OR: 1.8, P < 0.001), respiratory comorbidity (OR: 1.6, P < 0.001), resection at urgent operation (OR: 2.2, P < 0.001), perioperative transfusion (OR: 1.6, P < 0.010), stoma constructed (OR: 1.4, P < 0.001), and operation lasting ≥3 hours (OR: 1.6, P < 0.001).

Conclusions: 

These features can be used to alert medical and nursing staff to patients likely to experience prolonged ileus after bowel resection so that they can be monitored closely in the postoperative period and available treatments targeted toward them. These features may also be useful in the research context to facilitate the more efficient selection of high-risk patients as subjects in clinical trials of prevention or treatment.

© 2013 by Lippincott Williams & Wilkins.

You can read the full text of this article if you:

Access through Ovid